Status:
WITHDRAWN
Add-on to Cognitive, Event-Related Potentials (ERP) and Electroencephalogram (EEG) Asymmetry in Affective Disorders
Lead Sponsor:
New York State Psychiatric Institute
Conditions:
Depressive Illness
Eligibility:
All Genders
18-66 years
Phase:
PHASE4
Brief Summary
Depressed patients unremitted after monotherapy with citalopram or bupropion will remit following six weeks treatment with the combination of citalopram and bupropion.
Detailed Description
Participants in another study who did not remit during 12 weeks treatment with citalopram (to 40 mg/d) or bupropion (to 450 mg/d) will have citalopram (to 40 mg/d) or bupropion (to 450 mg/d) added for...
Eligibility Criteria
Inclusion
- non-remission in Protocol #6559R
- age 18-66
- signs informed consent
- physically healthy
Exclusion
- bipolar disorder
- history of psychosis
- history of anorexia nervosa or bulimia
- history of seizure disorder, significant brain trauma or other medical reason to suspect increased seizure risk
Key Trial Info
Start Date :
June 29 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2016
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03278938
Start Date
June 29 2012
End Date
January 1 2016
Last Update
March 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032